###### Key messages

What is already known about this subject?
=========================================

-   Globally declining prevalence of blindness is an already established fact. Cataract still remains the leading cause of blindness measuring over 80% of avoidable blindness according to a previous pan-India survey published in 2008.

What are the new findings?
==========================

-   The present study reports significant decline in prevalence of blindness compared with previous studies. It also establishes a changing pattern of blindness in urban India---declining proportion of cataract blindness and emerging burden of posterior segment diseases (PSDs) as cause of blindness. Cataract surgical coverage is demonstrated to be excellent in this study depicting success of control strategies.

How might these results change the focus of research or clinical practice?
==========================================================================

-   These results emphasise the need to have similar surveys in rural areas and other states of India to see variation in prevalence and pattern of blindness. This study also identifies the need to strengthen services to operate on cataracts at earlier immature stages and to tackle the emerging burden of PSD.

Introduction {#s1}
============

Despite collective global efforts, cataract continues to remain the principal cause of avoidable blindness. Demographic and epidemiological transition coupled with inadequate service delivery initiatives and health inequities across the world suggests that more efforts are required to address the cataract blindness.[@R1] There has been a significant thrust in India by governmental, non-governmental and private agencies to tackle this. Resultant improvement in cataract services has decreased the proportion of blindness attributable to cataract, but surveys[@R4] suggest more work is needed to ensure universal eye health.[@R2]

Prevalence of blindness globally has shown significant decline over past two decades[@R6] and shows a wide variation across various states of India.[@R4] This variation could be due to factors such as access to care, variable levels of economic development and social factors (housing, gender bias).[@R1]

Assessment of magnitude of blindness is crucial for planning an eye care programme and to assess impact of services. This requires generating disaggregated information for assisting and facilitating service delivery planning.

Pune is an urban metropolitan region having a population of 5.5 million.[@R10] Pune city is the second largest city and an industrial, educational hub in Maharashtra state of western India. There are over 400 ophthalmologists in Pune municipal area who work in private (70%), public (10%) or NGO (15%) sector and the remaining 5% do not practise (personal communication). Nearly 40% of Pune population lives in slums. Eye care services in urban marginalised populations are a challenge, and to the best of our knowledge, until now, no such organised and systematic effort exists in India. One of the important objectives of 'global action plan' 2014--2019 for universal eye health is to generate evidence on magnitude and causes of visual impairment (VI) and eye care services.[@R2] Hence, estimating prevalence of blindness and its causes was planned through a rapid assessment of avoidable blindness (RAAB) survey in the Pune municipal corporation area to develop an evidence base for planning urban eye care services.

RAAB is a survey methodology designed for assessment of prevalence and causes of blindness and VI in the population over 50 years of age.[@R11] It has been used in over 330 population surveys of eye health worldwide.[@R13]

Methods {#s2}
=======

The survey used the RAAB methodology along with additional diabetic retinopathy (DR) module. In the present paper, results pertaining only to RAAB module are presented. Findings of the DR module are presented elsewhere.[@R14] Each survey team consisted of an ophthalmologist, an optometrist, a study coordinator and a technician. Three such teams were trained by a certified RAAB trainer. As part of the training, each team underwent interobserver variability (IOV) testing to check agreement on visual acuity (VA) assessment, lens examination, main cause of VI and diagnosis of DR grade between each team and a gold standard. A Kappa value of 0.6 or more was considered as acceptable. Kappa values of IOV for the first three assessments ranged between 0.86 and 0.89 and the same for grading of DR was 0.65.

Sample size calculation {#s2-1}
-----------------------

Pune municipal corporation area has a population of 3 million (16% persons aged \>50 years).[@R12] The sample size was calculated using the RAAB software. The estimated prevalence of DR was used as the parameter for sample size estimation, as this was one of the main objectives. A sample size of 3527 participants was calculated based on an expected prevalence of DR of 3.8% in the target age group[@R15] and prevalence of blindness of 3.6%[@R5] relative precision of 22% of the estimate (±0.84%), non-compliance of 10%, 95% CIs and a design effect of 1.6. Using the standard RAAB approach, participants were enumerated in 60 clusters of 60 adults aged 50 and above.

Updated data from the electoral list of 2017 served as the sampling frame (most updated population data as per standard RAAB protocol). The updated electoral list included migrant workers who had moved to Pune before 2017. Electoral wards served as primary sampling units. The population (\>18 years) of the smallest and the largest sampling unit was 508 and 850, respectively (average population 630). Each randomly selected sampling unit was divided into multiple segments (compact segment sampling) based on the expected proportion of the population 50 and above. Given that 16% of the population are expected to be in this age group, it was calculated that an all-age segment population size of 375 would identify a cluster of approximately 60 persons above 50 years of age. Each sampling unit was therefore divided into equal segments of approximately 375 people of all ages. To avoid bias, one segment was then randomly selected by a local community leader using a folded chit lottery method from among all segments in the sampling unit. The date and time of visit was publicised at least a day prior in the survey area to minimise non-response. Two teams then visited separate areas (door-to-door visit) in the selected segment until they examined 30 persons each. If an eligible person in the household was not available/refused or was unable to comply, he/she was considered a non-respondent. In the selected segments having high-rise apartments, each team started from the opposite end (first floor and top floor). Each consecutive house was visited until 30 persons were examined by each team. In case of falling short of the required number, the team(s) went to the adjacent apartment building to complete the sample for that day. This method was implemented in the pilot cluster and found suitable in the urban setting.

Examination and data collection {#s2-2}
-------------------------------

Data on occupation and health insurance status were collected. There is a provision of two optional fields in standard RAAB data collection form. Aforementioned data were collected to study the association between them and the prevalence of blindness/DR as well as coverage of these services. All participants then underwent VA (presenting and pinhole) testing in each eye. VA assessment was completed using Snellen's tumbling E chart, and participants were labelled as having normal vision (6/12 or more)/VI (6/18--3/60)/blindness (\<3/60) as per WHO's convention and the RAAB survey methodology V.6.[@R16] Participants then underwent anterior segment evaluation with a light source and a detailed lens examination for red glow by direct ophthalmoscope. All eyes with early VI or worse (\<6/12) were examined with a direct ophthalmoscope to ascertain the cause. Each participant was asked about history of diabetes mellitus (DM) and then underwent random blood sugar examination using a glucometer. Persons with DM were dilated as part of DR module of the RAAB to check retinal status. Fundus was examined by a trained ophthalmologist using indirect ophthalmoscope (Appasamy Associates, India) and a 20 D lens (Volk, Germany) to ascertain DR status. Details of the methods of DR module are presented in another paper.[@R14] For the rest of the subjects with early VI or worse, if no obvious cataract/anterior segment or obvious posterior segment cause (such as age-related macular degeneration (ARMD), DR) was identified, eyes were labelled as having 'other' posterior segment disease (PSD).

If there was a primary and a secondary cause of blindness or VI, only the primary cause was recorded as principal cause. If there were two or more primary disorders, equally contributing to the visual loss, then the cause that was easiest to treat or to prevent was recorded as primary cause as per WHO convention. This was done for each eye as well as in the individual (better eye) as per RAAB protocol.

Data entry and analysis {#s2-3}
-----------------------

Data were entered into the RAAB6 software on a daily basis by two persons separately to ensure validity and consistency. Data cleaning was performed if required before the teams went to survey next day. Descriptive statistics were generated by the RAAB6 software. Custom analysis of causes of cataract surgical outcome data was conducted after exporting RAAB data into Excel. Statistical tests of association between categorical variables were carried out in a statistical software (Stata IC V.14; StataCorp LLC, College Station, Texas, USA).

Patient and public involvement {#s2-4}
------------------------------

There was no patient involvement in planning and executing this study. A meeting was planned after completion of this survey to disseminate results to district health officials, NGO representatives and office bearers of local ophthalmology and diabetes associations as well as to general public through local print and electronic media.

Results {#s3}
=======

The response rate for the survey was 89.5% (3221/3600), and 55.3% were women. Proportion of non-respondents was as follows: not available, 4.9%; refusals, 4.1%; unable to comply, 1.5%.

Age and gender distribution of the people in the sample is shown in [table 1](#T1){ref-type="table"}.

###### 

Age and gender distribution in the sample

  Age (years)   Men          Women        Total
  ------------- ------------ ------------ -------------
  50--59        604 (41.9)   841 (47.2)   1445 (44.9)
  60--69        501 (34.8)   603 (33.9)   1104 (34.3)
  70--79        246 (17.1)   233 (13.1)   479 (14.9)
  \>80          89 (6.2)     104 (5.8)    193 (6.0)
  Total         1440 (100)   1781 (100)   3221 (100)

For women, the population age distribution of the examined geographical area was similar to sample distribution. However, men were under-represented in the 50--59 age group (sample 41.9% vs survey area 50.7%) and over-represented in the older age groups (60--69, 34.8% vs 31% and 70--79, 17.1% vs 13.2%, respectively).

Of all the examined persons, 1444 (44.8%) were daily labourers and 70 (2.1%) did not earn wages. Also, 13.9% (447/3221) had some form of health insurance.

Sample prevalence of blindness (not adjusted for age and sex) was 1.4% (95% CI 1 to 1.9). Total prevalence of VI (early VI to blindness) was 29.8%. [Table 2](#T2){ref-type="table"} shows age-standardised and sex-standardised magnitude of blindness and visual impairment. Prevalence of blindness and severe VI was similar in men and women, but that of moderate VI, early VI and functional low vision was significantly higher in women than in men as shown in [table 2](#T2){ref-type="table"}.

###### 

Age-standardised and sex-standardised magnitude of blindness and visual impairment

                          Men      Women                Total                                    
  ----------------------- -------- -------------------- -------- --------------------- --------- ---------------------
  Blindness               6365     1.4 (0.8 to 2.1)     5487     1.3 (0.7 to 1.8)      11 852    1.3 (0.9 to 1.8)
  Severe VI               5692     1.4 (0.8 to 1.9)     5667     1.3 (0.8 to 1.8)      11 360    1.3 (0.9 to 1.7)
  Moderate VI             47 515   10.6 (8.7 to 12.4)   67 293   15.4 (13.1 to 17.8)   114 807   13.0 (11.2 to 14.7)
  Early VI                53 056   11.8 (10 to 14.4)    72 761   16.7 (14.5 to 18.8)   125 820   14.2 (12.7 to 15.7)
  Functional low vision   5094     1.1 (0.6 to 1.7)     11 132   2.6 (1.8 to 3.3)      16 230    1.8 (1.3 to 2.3)

VI, visual impairment.

Prevalence of blindness by age group is shown in [table 3](#T3){ref-type="table"}.

###### 

Blindness prevalence by age group

                  Men   Women              Total                            
  --------------- ----- ------------------ ------- ------------------- ---- ------------------
  50--59 years    2     0.3 (0.0 to 0.8)   5       0.6 (0.1 to 1.1)    7    0.5 (0.1 to 0.9)
  60--69 years    7     1.4 (0.4 to 2.4)   5       0.8 (0.1 to 1.5)    12   1.1 (0.5 to 1.7)
  70--79 years    12    4.9 (2.4 to 7.4)   5       2.2 (0.4 to 3.9)    17   3.6 (2.1 to 5.0)
  80+ years       3     3.4 (0.0 to 7.2)   7       6.7 (1.7 to 11.7)   10   5.2 (1.7 to 8.7)
  All 50+ years   24    1.7 (1.0 to 2.3)   22      1.2 (0.7 to 1.8)    46   1.4 (1.0 to 1.9)

Principal causes of blindness and visual impairment are shown in [table 4](#T4){ref-type="table"}. Overall, the proportion of avoidable causes of blindness/VI was as follows: blindness, 69.6%; severe VI, 93%; moderate VI, 90.2%; early VI, 94.6%.

###### 

Principal causes of blindness and visual impairment in persons

  Cause                                 Blindness   Severe VI   Moderate VI   Early VI
  ------------------------------------- ----------- ----------- ------------- ------------
  1\. Refractive error                  1 (2.2)     1 (2.3)     59 (13.4)     214 (44.7)
  2\. Aphakia (uncorrected)             0 (0.0)     0 (0.0)     0 (0.0)       0 (0.0)
  3\. Cataract untreated                21 (45.7)   34 (79.1)   293 (66.6)    202 (42.2)
  4\. Cataract surgical complications   3 (6.5)     3 (7.0)     36 (8.2)      35 (7.3)
  5\. Trachomatous CO                   0 (0.0)     0 (0.0)     0 (0.0)       0 (0.0)
  6\. Non-trachomatous CO               2 (4.3)     2 (4.7)     5 (1.1)       0 (0.0)
  7\. Phthisis                          1 (2.2)     0 (0.0)     0 (0.0)       0 (0.0)
  8\. Onchocersiasis                    0 (0.0)     0 (0.0)     0 (0.0)       0 (0.0)
  9\. Glaucoma                          4 (8.7)     0 (0.0)     1 (0.2)       2 (0.4)
  10\. Diabetic retinopathy             0 (0.0)     0 (0.0)     3 (0.7)       0 (0.0)
  11\. ARMD                             2 (4.3)     1 (2.3)     7 (1.6)       8 (1.7)
  12\. Other PSD                        12 (26.1)   2 (4.7)     36 (8.2)      17 (3.5)
  13\. Globe/CNS abnormalities          0 (0.0)     0 (0.0)     0 (0.0)       1 (0.2)
  Total                                 46 (100)    43 (100)    440 (100)     479 (100)

ARMD, age-related macular degeneration; CNS, central nervous system; CO, corneal opacity; PSD, posterior segment disease; VI, visual impairment.

Overall posterior segment diseases (glaucoma, DR, ARMD and other PSD) accounted for 39.1% of blindness---next only to cataract blindness. Extrapolating this proportion to the magnitude of blindness as stated in [table 2](#T2){ref-type="table"} gives an estimate of persons blind from various causes as follows: cataract, 5415; overall PSD, 4633.

[Table 5](#T5){ref-type="table"} shows outcome by presenting VA category. Cumulative proportion of borderline and poor outcome was 32.4% (385/1190).

###### 

Visual outcome after cataract surgery

                             Men          Women        Total
  -------------------------- ------------ ------------ ------------
  Very good: can see 6/12    250 (53.8)   312 (43.0)   562 (47.2)
  Good: can see 6/18         94 (20.2)    149 (20.6)   243 (20.4)
  Borderline: can see 6/60   76 (16.3)    194 (26.8)   270 (22.7)
  Poor: cannot see 6/60      45 (9.7)     70 (9.7)     115 (9.7)
  Total                      465 (100)    725 (100)    1190 (100)

Of all the eyes operated on for cataract, 18 (1.5%) were aphakic. Of the 385 persons with borderline/poor outcome, 121 were men and 164 were women. Causes of borderline/poor outcome by gender were as follows: ocular comorbidity---men 59 (48.8%), women 141 (53.4%); surgical complications---men 18 (14.8%), women 50 (18.9%); refractive error---men 13 (10.8%), women 28 (10.6%); postoperative complications---men 31 (25.6%), women 45 (17.1%).

Cataract surgical coverage (CSC---proportion of individuals operated on, of all cataract cases) was 96.7% (men 95.6% vs women 97.5%) for those with blindness and 92.8% (men 91.5% vs women 93.6%) for those with severe VI. There was no gender disparity as far as CSC was concerned. Occupation and insurance status of the participants were not associated with cataract surgical status (p\>0.5).

'Need not felt' (15/41, 36.6%; men 31.6% vs women 40.9%) and 'cost' (13/41, 31.7%; men 47.4% vs women 18.2%) were the most common barriers for cataract surgery.

All data relevant to the study are included in the article or uploaded as online supplementary information ([online supplementary files 1--7](#SP1 SP2 SP3 SP4 SP5 SP6 SP7){ref-type="supplementary-material"}).

Discussion {#s4}
==========

In the last decade, several RAAB surveys have been conducted in India[@R5] and globally.[@R17] In the previous pan-India RAAB study,[@R5] 21.5% of the population was from urban region and the rest from rural region. Pune municipal area where the present survey was conducted is an urban, densely populated region in western India. Nearly 40% of the population in this area resides in slums. Eye care services in this region are provided by government, private or NGO facilities. With a high number of ophthalmologists, accessibility of services is expected to be good.

Response rate for the survey was very good (89.5%). There was slight under-representation of men in the younger age group and over-representation in the older age group. This was because most men in the working age were away during the survey period. There was no gender difference in prevalence of blindness. Western Maharashtra and Pune in particular is known to have less gender bias, indicators being maternal mortality and childhood mortality rates among the lowest in the country and participation of female work force being higher than the national average.[@R23] However, higher prevalence of moderate VI (MVI), early VI (EVI) and functional low vision among women is suggestive of gender bias when it comes to accessing eye care.

Overall prevalence of blindness was 1.3% (95% CI 0.9 to 1.8). This prevalence is much less than a previous nationwide RAAB survey where the prevalence was 3.6% (urban sample---2.9%).[@R5] The prevalence of blindness in the present study is half of that reported from urban regions in the previous study. There are no baseline data available from Pune and the previous RAAB data from other parts of India cannot be directly compared with findings from the present study. However, it could be hypothesised that low prevalence is suggestive of a strong commitment of stakeholders to implement strategies of the National Program for Control of Blindness, India. The prevalence of blindness showed a rising trend with advancing age. Higher prevalence of blindness with increasing age clearly explains association between increased longevity and blinding eye diseases. Wide 95% CI of the prevalence values in higher age groups (\>70 years) was because the sample in that age group was much smaller.

Cataract surgical coverage was excellent and equitable between genders for those blind due to cataract. Cataract surgical rate of close to 6000 as well as high ratio of over 130 ophthalmologists per million population is perhaps responsible for a very high CSC in Pune city. Hence, access to cataract services is not a major barrier and there is no gender disparity for uptake of these services. Low prevalence of blindness compared with previous RAAB survey and good CSC means persons with cataract are accessing eye care services early. Strengthening of the eye health system and partnership building between government and NGOs is necessary to tackle increasing workload of immature cataracts.

Despite excellent CSC, cataract still accounted for nearly half of the causes of blindness. Overall posterior segment diseases accounted for next common causes. With improving socioeconomic status and better access to cataract services, proportion of blindness due to PSD is likely to increase in urban India. Glaucoma accounted for 8.7% of the blindness. This proportion is almost double the previous estimates (4.4%).[@R5] There is also a possibility that in participants with coexisting glaucoma and cataract, the latter was selected as the principal cause of blindness leading to underestimates of glaucoma diagnosis. Cataract was the most common cause of severe VI and MVI. Uncorrected refractive errors accounted for most cases of EVI. Intervention in the form of spectacles can lead to significant reduction in prevalence of EVI.

In the present study, a third of the participants operated on for cataract had borderline/poor outcome. In urban pockets of Argentina (similar prevalence of blindness and similar CSC), less than a fifth of cataract cases operated on had borderline/poor visual outcome.[@R24] Nearly half (46.5%) of the causes of borderline/poor outcome in the present study were either treatable or preventable. They included posterior capsule opacity, surgical complications and refractive error in that order of frequency. Ocular comorbidities and surgical complications as causes of poor/borderline outcome were more common in women and postoperative complications were more common in men. Strengthening cataract surgical training programmes and closely monitoring surgical outcomes can help reduce the rate of surgical complications further. These findings also emphasise the need to improve access to simple interventions such as YAG capsulotomy. The proportion of men with 'very good' outcome was higher than that of women whereas in 'borderline outcome' category, there were more women. This 'very good' outcome does have clinical/visual function significance in those who have undergone cataract surgery.

The most common barrier for accessing cataract surgical services was 'need not felt', and this was more commonly reported by women than by men. This could be because women in Asian societies have a different health-seeking behaviour and they often access care late due to lack of felt need.[@R25] At the root of this may lie a larger issue of lack of women empowerment and women feeling more dutybound towards their domestic responsibilities. 'Cost' was a barrier reported by nearly a third of those blind due to cataract, more so by men. This underlines the financial challenges faced by urban poor in accessing services. National Urban Health Mission envisages to meet healthcare needs of the urban poor, by providing essential healthcare services and reducing their out-of-pocket expenses for treatment.[@R26]

Using this approach can present a good baseline for organising and planning eye care services for the underprivileged community in Pune. Partnership with NGOs/other stakeholders for providing services would benefit the urban poor. Social marketing of cataract services in the poor areas might improve uptake further.

The findings of this study were disseminated through a meeting with municipal health authorities, district ophthalmic surgeon, president of local ophthalmology society and other important stakeholders such as secretaries of associations for senior citizens and persons with DM. Facilities providing free surgeries/treatment for poor were identified and linked with senior citizen groups and local community leaders. Findings were also disseminated through local print and electronic media to encourage needy persons to seek care.

There are certain limitations to this study. This was carried out in an urban area of a relatively developed state of Maharashtra. Hence, results of this survey may not be generalisable to rural parts of the state/India. Baseline data for the survey region were not available; hence, it cannot be said whether or not prevalence of blindness is on the decline.

In conclusion, looking at findings from the present study and from urban data of previous RAAB survey in India,[@R5] it can be hypothesised that prevalence of blindness is showing a declining trend in urban pockets of India. Cataract still remains a major cause of blindness despite excellent surgical coverage, with PSD emerging as an important cause. Health systems in cities need to be strengthened to tackle cataracts at early stages.
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